BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND KDM6A, O15550, UTX, 7403, ENSG00000147050, DKFZp686A03225, RP13-886N14_3, MGC141941, bA386N14_2
92568 results:

  • 1. A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.
    Kilickap S; Ozturk A; Karadurmus N; Korkmaz T; Yumuk PF; Cicin I; Paydas S; Cilbir E; Sakalar T; Uysal M; Yesil Cinkir H; Uskent N; Demir N; Sakin A; Dursun OU; Aver B; Turhal NS; Keskin S; Tural D; Eralp Y; Bugdayci Basal F; Yasar HA; Sendur MAN; Demirci U; Cubukcu E; Karaagac M; Cakar B; Tatli AM; Yetisyigit T; Urvay S; Gursoy P; Oyan B; Turna ZH; Isikdogan A; Olmez OF; Yazici O; Cabuk D; Seker MM; Unal OU; Meydan N; Okutur SK; Tunali D; Erman M;
    Medicine (Baltimore); 2024 May; 103(21):e37972. PubMed ID: 38787994
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Two cases of inflammatory myofibroblastic tumor treated with targeted drugs: A case report.
    Liu M; Zhu D
    Medicine (Baltimore); 2024 May; 103(21):e38136. PubMed ID: 38787978
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland: A case report and literature review.
    Zhong Q; Yan Y; Li S
    Medicine (Baltimore); 2024 May; 103(21):e38303. PubMed ID: 38787969
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid Leukemia.
    Basingab FS; Alzahrani RA; Alrofaidi AA; Barefah AS; Hammad RM; Alahdal HM; Alrahimi JS; Zaher KA; Algiraigri AH; El-Daly MM; Alkarim SA; Aldahlawi AM
    Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785930
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
    Ida N; Okura M; Tanaka S; Hosono N; Yamauchi T
    Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38785163
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. FAT1 inhibits the proliferation of DLBCL cells via increasing the m
    Wang TL; Miao XJ; Shuai YR; Sun HP; Wang X; Yang M; Zhang N
    Sci Rep; 2024 May; 14(1):11836. PubMed ID: 38782965
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical pharmacokinetics and pharmacodynamics of venetoclax, a selective B-cell lymphoma-2 inhibitor.
    Salem AH; Menon RM
    Clin Transl Sci; 2024 May; 17(5):e13807. PubMed ID: 38778732
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of the prevalence of Aeromonas spp., Campylobacter spp., and Clostridioides difficile in immunocompromised children with diarrhea.
    Heydari H; Iranikhah A; Ghasemi A; Mohammadbeigi A; Sadat-Mirei SA; Shams S; Kermani S
    BMC Infect Dis; 2024 May; 24(1):512. PubMed ID: 38778271
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Vitamin D and viral infections: Infectious diseases, autoimmune diseases, and cancers.
    Grant WB
    Adv Food Nutr Res; 2024; 109():271-314. PubMed ID: 38777416
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CAR T-Cell Immunotherapy in Minority Patients with lymphoma.
    Ghilardi G; Williamson S; Pajarillo R; Paruzzo L; Chen L; Grady C; Doucette A; Nemecek E; Gabrielli G; Barta SK; Svoboda J; Chong EA; Yelton R; Nasta SD; Landsburg DJ; Ugwuanyi O; Chen AI; Schachter L; White G; Ballard HJ; Weber E; Curley C; Porter DL; Garfall AL; Hwang WT; Guerra CE; Maziarz RT; Schuster SJ; Ruella M
    NEJM Evid; 2024 Apr; 3(4):EVIDoa2300213. PubMed ID: 38776868
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL.
    Wang X; Deng Y; He G; Lai S; Li Y; Zhang S; He Y; Han Y; Zhang L; Su Y; Liu F; Yi H
    Hematology; 2024 Dec; 29(1):2356300. PubMed ID: 38776229
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
    Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
    Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
    Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
    Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy.
    Nakamura N; Jo T; Arai Y; Kitawaki T; Nishikori M; Mizumoto C; Kanda J; Yamashita K; Nagao M; Takaori-Kondo A
    Clin Exp Med; 2024 May; 24(1):105. PubMed ID: 38771501
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Rare Case of Congenital Nephrogenic Diabetes Insipidus Associated with Aquaporin 2 Gene Mutation and Subsequent Acute Lymphoblastic Leukemia: Impact of Steroids on Kidney Function.
    Al-Thiabat H; Abu-Aqoulah A; Kanaan D; Matalka MI; Al-Sweedan S
    Am J Case Rep; 2024 May; 25():e943597. PubMed ID: 38769718
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Activated phosphoinositde 3-kinase (PI3Kδ) syndrome: an Italian point of view on diagnosis and new advances in treatment.
    Lougaris V; Piane FL; Cancrini C; Conti F; Tommasini A; Badolato R; Trizzino A; Zecca M; De Rosa A; Barzaghi F; Pignata C
    Ital J Pediatr; 2024 May; 50(1):103. PubMed ID: 38769568
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Proteomic characterization and cytotoxic potential of proteins from Cuscuta (Cuscuta epithymum (L.) crude herbal product against MCF-7 human breast cancer cell line.
    Akhtar U; Khurshid Y; El-Aarag B; Syed B; Khan IA; Parang K; Ahmed A
    BMC Complement Med Ther; 2024 May; 24(1):195. PubMed ID: 38769554
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Treatment intensity affects immune reconstitution even after childhood cancer not treated with hematopoietic stem cell transplantation.
    Antikainen E; Grönroos M; Huurre A; Korhonen L; Peltola V; Lähteenmäki P; Schuez-Havupalo L
    Cancer Rep (Hoboken); 2024 May; 7(5):e2069. PubMed ID: 38767518
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical Features of Cutaneous Paraneoplastic Syndromes in Hodgkin lymphoma.
    McCormick BJ; Zieman D; Sluzevich JC; Alhaj Moustafa M
    J Investig Med High Impact Case Rep; 2024; 12():23247096241255840. PubMed ID: 38767173
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4629.